United Therapeutics Corporation (UTHR) Balance Sheet
As of 2026-06-30 (10-Q), United Therapeutics Corporation (UTHR) reported total assets of $7.2B, total liabilities of $819.8M and shareholders' equity of $6.4B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $1.8B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
UTHRUnited Therapeutics CorporationFollow UTHR — free
—
Price chart with a free account
- Market cap
- 25.2B
- P/E TTM
- 21.0
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.25 | 0.17 | 0.16 | 0.28 | 0.40 | 0.83 | 1.02 | 0.71 | 0.67 | 0.74 | 0.74 | 0.89 | 0.96 | 1.21 | 1.70 | 1.56 | 1.80 | |
| Short-term investments | — | — | — | — | — | — | 0.03 | 0.22 | 0.75 | 0.75 | 1.10 | 1.04 | 1.88 | 1.79 | 1.57 | 1.36 | 0.86 | |
| Receivables | 0.07 | 0.09 | 0.12 | 0.13 | 0.16 | 0.19 | 0.21 | 0.30 | 0.18 | 0.15 | 0.16 | 0.20 | 0.22 | 0.28 | 0.28 | 0.35 | 0.31 | |
| Inventory | 0.04 | 0.05 | 0.04 | 0.05 | 0.07 | 0.08 | 0.10 | 0.11 | 0.10 | 0.09 | 0.09 | 0.09 | 0.10 | 0.11 | 0.16 | 0.18 | 0.19 | |
| Current assets | 0.76 | 0.56 | 0.67 | 0.91 | 0.96 | 1.28 | 1.42 | 1.45 | 1.77 | 1.86 | 2.17 | 2.32 | 3.38 | 3.55 | 3.87 | 3.70 | 3.48 | |
| Total assets | 1.43 | 1.52 | 1.63 | 2.09 | 1.88 | 2.18 | 2.33 | 2.88 | 3.40 | 3.91 | 4.62 | 5.17 | 6.04 | 7.17 | 7.36 | 7.88 | 7.22 | |
| Current liabilities | 0.43 | 0.21 | 0.18 | 0.69 | 0.50 | 0.44 | 0.33 | 0.44 | 0.28 | 0.46 | 0.32 | 0.31 | 0.34 | 0.80 | 0.74 | 0.56 | 0.61 | |
| Long-term debt | 0.07 | 0.07 | 0.07 | 0.00 | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Short-term debt | 0.24 | — | — | 0.22 | 0.13 | 0.01 | — | — | — | — | — | — | — | — | — | — | — | |
| Total liabilities | 0.54 | 0.56 | 0.53 | 0.78 | 0.62 | 0.58 | 0.46 | 0.76 | 0.59 | 1.13 | 1.22 | 1.21 | 1.25 | 1.18 | 0.92 | 0.78 | 0.82 | |
| Shareholders' equity | 0.88 | 0.95 | 1.08 | 1.26 | 1.24 | 1.59 | 1.85 | 2.10 | 2.79 | 2.78 | 3.40 | 3.96 | 4.80 | 5.98 | 6.44 | 7.10 | 6.40 |
USD billions · SEC XBRL
United Therapeutics Corporation — questions
- How much cash does United Therapeutics Corporation have?
- $1.8B in cash and cash equivalents as of 2026-06-30.
- What are United Therapeutics Corporation's total assets?
- $7.2B as of 2026-06-30.
- What is United Therapeutics Corporation's shareholders' equity?
- $6.4B as of 2026-06-30.
Every figure on this page comes from United Therapeutics Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.